To study the expression of integrins at the erythroid progenitor level we isolated selected populations of cells from human fetal liver after immunoadherence to anti-p, integrin (CD18) coated plates. These CD18 adherent cells (CD18-Ad), in contrast to CD18 nonadherent cells (CDl&NAd), have a blastlike cell morphology and are highly enriched in all progenitor types (14% to 37% progenitors). By several criteria progenitor cells present in CD18-Ad cells appear to have a higher proliferative potential and diversity than the ones found in CD18-NAd, which were mostly later erythroid progenitors. Positivity of CD18-Ad cells with the common p, integrin (CD18) is largely attributable to expression of aL (CD1 l a ) chain, rather than q , , (CDllb). CDlla is present in all HE IMPORTANCE of adhesive interactions in he-T matopoiesis has been well established.',2 Despite recent significant progress, delineation of all the specific molecules involved in these interactions, their target cells, and the specific stage of differentiation at which they occur is far from complete. The best studied surface proteins mediating cell adhesion are the integrin~. 
present study was to investigate the expression of P2 integrins at the hematopoietic progenitor level with a particular focus on expression by early erythroid progenitors. For these studies, we have used fetal liver samples, as erythropoiesis is predominant at that stage and granulomonocytopoiesis is minimal.
In contrast to previous findings with adult bone marrow, we have found abundant expression of selected members of p2 and p, integrins in early erythroid as well as nonerythroid progenitors. Specifically, we found that CD1 lafCD18 or a,/ p2 molecules are present in early erythroid progenitors (BFUe), but they are selectively lost during downstream erythroid differentiation. In contrast to CDlla, CDllb appears to be absent from erythroid or other progenitors; however, its expression is progressively enhanced during downstream granulomonocytic differentiation. Thus, we have uncovered a divergent pattern of expression between CDlla(a,) and CDllb(a,) at early stages of erythroid differentiation. Furthermore, we have found that I-CAM, the counterreceptor for CDlla, is also concurrently expressed in early erythroid progenitors but, like CDlla, its expression is lost at the erythroid precursor level. In contrast to p2 integrin, p, integrin of the VLA-4 type is highly expressed both at the erythroid progenitor and erythroid precursor level.
Taken together, our data suggest that erythroid progenitors express a complement of specific integrin molecules, some of which are carried through the later stages of erythroid differentiationfmaturation, whereas others are selectively lost.
5,000 per plate) in I-mL aliquots in methylcellulose medium in 35-mm plastic Petri plates (NUNC, Naperville, IL). The composition of the methylcellulose culture medium was as follows: 0.9% methylcellulose (Fisher Scientific, Pittsburgh, PA), 1% bovine serum albumin (BSA; Calbiochem, San Diego, CA), 30% FCS (Intergen, Purchase, NY), mol/L 2-mercaptoethanol (Eastman Kodak, Rochester, NY) in IMDM (GIBCO Labs, Grand Island, NY). To the above culture components, either 10% leukocyte-conditioned medium (LCM) from phytohemagglutinin (PHA)-stimulated lymphocytes" or the following growth factors were added (either alone or in combination): erythropoietin (Epo) at 2.0 to 3.0 UlmL, interleukin-3 (IL-3) at 100 U/mL, granulocytemacrophage colony-stimulating factor (GM-CSF) at 45 ng/mL, and G-CSF at 6 ng/mL (all human recombinant cytokines were a gift from Genetics Institute, Cambridge, MA). Cells were incubated for 10 to 16 days in 5% C02 in high humidity at 37°C. Erythroid bursts (BFUe) were defined as single or multiple units, more than 100 cells, with smooth outlines and were evaluated at day 12. Colony-forming unit granulocyte macrophage (CFU-GM) colonies were also identified morphologically, and were evaluated at days 10 to 12. Mixed colonies were defined as colonies with a granulocytic or macrophage as well as a hemoglobinized segment. Colony data are expressed as the mean (with standard error of the mean) of four or more colony counts (from replicate cultures or equal sample areas) for each experimental variable, calculated to conform to a standard "inoculum" (usually lo-' per milliliter). CFUe were evaluated in plasma clot cultures as mature wellhemoglobinized small clusters of cells at days 5 and 6. Plasma clot cultures consisted of the same components as the methylcellulose cultures (except methylcellulose), plus 10% bovine citrated plasma (Irvine Scientific, Irvine, CA), and 10% beef embryo extract (GIBCO).
In several experiments, cells from the two fractionated populations (ie, CD18-Ad and CD18-NAd) were placed in suspension culture at 10" per milliliter in the presence of 10% LCM and IL-3 (100 U/mL). CD18-NAd cells were erythroblast-depleted before culture by panning with monoclonal antibody (MoAb) SFL23.6, which has specificity for erythroblasts and erythrocytes.'* At 2-day intervals, samples were taken for cell counting, morphologic observations, and replating in methylcellulose cultures.
This was performed according to previously described Briefly, polystyrene plates were coated with anti-CD18, anti-CD34, or anti-CD1 l a MoAbs (15 pg/mL in Tris pH 9.5). Cells were added to these plates and incubated at 4°C for 1 hour. The plates were washed with cold phosphate-buffered saline plus 1% BSA (PBS/BSA) and the nonadherent cells were gently aspirated. Adherent cells were recovered by vigorous pipetting of the entire plate surface with warm IMDM/FCS.
The following MoAbs were used in this study: anti-CD18 (60.3"), anti-CD1 l a (LFA-1; Accurate Chem Co, Westbury, 
RESULTS

Isolation of p2 inregrin expressing cells by "panning."
Freshly prepared fetal liver cell suspensions (gestational age 50 to 80 days) were subjected to direct immune adherence (panning) using anti-CD18 (p.)-coated plates. Adherent cells recovered from panning plates represented 1% to 4% of original cell suspensions, and morphologically, in Giemsa-stained preparations, appeared as large, blastlike cells (majority of cells) or as small, lymphocyte-like cells (Fig 1) . Occasional macrophages and differentiated cells were sometimes present. Starting cell populations, nonadherent cells, and adherent cells recovered from panning plates were used for all subsequent studies.
Clonogenic progenitors in p2 integrin "adherent" (CD18-Ad) populations. To determine the presence and concentration of clonogenic progenitors in CD18 adherent (CD18- For personal use only. on October 30, 2017. by guest www.bloodjournal.org From Ad) and CD18 nonadherent (CDl8-NAd) populations, we plated these as well as unfractionated cells in methylcellulose clonal cultures. Results from six such experiments are shown in Fig 2. The concentration of progenitor cells (of all categories) in CD18-Ad cells was from 14% to 37%. This contrasted with 0.2% to 1% in original cells and 0.05% to 0.9% in CDl8-NAd cells. Thus, hematopoietic progenitors were concentrated up to 260-fold in CD18-Ad cells. Furthermore, in one experiment, we sorted small and large cells from CD18-Ad cells on the basis of their light scattering properties (Fig 3) and plated these in clonal cultures (1,000 to 5,000 cells/mL). Large cells gave a total of 29.7% colonics, whereas small cells yielded only 0.3% colonies. It is of interest not only that clonogenic progenitors reside among the large CDl8-Ad cells, but also that these cells are more intensely labelcd with anti-CDlS, as compared with small cells (Fig 3) .
To further define the spectrum of progenitors present among CDl8-Ad cells, we categorized the colonies in four experiments as BFUe, CFU-GM + M, or CFU-Mix when both crythroid and nonerythroid components were present (Tablc 1). These cultures were performed under optimal conditions of stimulation of all colony varieties, containing in addition to Epo, IL-3, GM-CSF, and G-CSF. When only Epo was present, very few CFU-GM and no CFU-Mix were found (data not shown). In the presence of IL-3 and GM-CSF. the number of BFUe did not change significantly, whereas the number of CFU-GM + M was greatly increased. In addition to high content of progenitors of all types in CD18-Ad cells, these cells also produced the highest proportion of large (over 0.35 mm in diameter), macroscopic colonies (58% were of large size in CD18-Ad), whereas the majority of colonies (56%) were of intermediate size in CDI8-NAd cells. The notion that CD18-NAd cells contained progenitors with less proliferative potential, presumably of morc mature type, was also supported by the fact that CD18-NAd had a higher proportion of CFUe type colonics, as indicated by thc BFUe to CFUe ratios pre- 
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FlTC Fluorescence sented in Table 2 . The ratio of BFUe to W e was 2 5 1 or 3:l in the original and CD18-NAd cells, respectively, whereas it was 19:l in CD18-Ad cells. To further test whether and to what degree progenitors present in CD18-Ad or CD18-NAd populations can amplify further in suspension cultures, we initiated liquid cultures using either CDl&Ad cells or CDlS-NAd cells and stimulation with IL-3 (100 U/mL) and 10% LCM (Table 3) . To make the comparison fair between these two populations, we removed the erythroblasts that represented greater than 80% of the population from the CD18-NAd. This was performed using two rounds of direct immunoadherence of CD18-NAd cells to plates coated with MoAb SFL23.6, which has specificity against erythroid cclls." Such a maneuver increased the concentration of progenitor cells, but did not alter the characteristics of colonies present (Table 3) . Both the total nucleated cell number and total progenitors present were amplified during the first week in culture, especially the ones present in CDl8-Ad (Table 3) . Progenitors present in CDlS-Ad cells increased up to 21-fold above their input number and remained above input number at the end of 2 weeks in culture. Although there was significant amplification of progenitor number present in the CDl8-NAd cell culture, most of the colonies generated were small ( of existing progenitors. By contrast, 50% of colonies generated by CD18-Ad cells by day 6 were of the large, macroscopic variety, providing further support that progenitors with higher proliferative potential were present in this population.
To test which a subunit(s) of p2 integrin were present in the CD18-Ad population, we labeled these cells (several hours at 37°C after adherence or after overnight incubation at 37°C to clear any surface-bound material) with anti-CDlla (LFA-1) or with anti-CDllb (Mac-1) antibodies (Fig 4) . CD18-NAd cells were concurrently labeled with the same antibodies. For strict comparison (because erythroblasts are negative in p2 integrins, see Fig 5) , we removed erythroblasts present in CD18-NAd cells by direct panning to anti-SFL-23.6 coated plates.
As seen in Fig 4 , most of the positivity of CD18-Ad cells with the common p2 chain is accounted for by the presence of CDlla rather than CDllb. In fact, CD18-NAd cells (minus erythroblasts) were overall more positive with CDllb than the CD18-Ad cells. Presumably the antigenic density of most of the CDllb-expressing cells, present in CD18-NAd, is low, as these cells failed to adhere to anti-CD18 coated plates. The above data suggest that significant enrichment of CDlla is present in CD18-Ad cells, whereas no such enrichment for CDllb was detected in these cells. Indeed, direct adherence to anti-LFA-1 coated plates (instead of anti-CD18) led to similar progenitor enrichment (Table 4) as occurred with anti-CD18. To further test whether or not progenitors present in CD18-Ad displayed CDllb, we removed from the CD18-Ad population any cells expressing CDl l b by subsequent panning to anti-CDllb coated plates. In three experiments (Table 4) , Expression of other cytoadheswn molecules. we found that a further enrichment in progenitor concentration occurred when CD1 lb-positive cells were removed from CD18-Ad cells or from concurrently isolated CD34-Ad cells. Altogether, the above data argue strongly for the presence of CDlla and the absence of CD'llb in progenitors.
In addition to p2 integrins, we examined whether VLA-4 was present both in CD18-Ad and CD18-NAd cells, mainly because its expression continues at the erythroblast level (see far right panel in Fig 6) , in contrast to VLA-5, which does not appear to be expressed in fetal erythroblasts. I-CAM-positive cells were greatly enriched among CD18-Ad cells, but not among the more differentiated cells present in CD18-NAd population. H-CAM appeared to be broadly distributed in both Ad and NAd cells; however, only a fraction of isolated erythroblasts expressed levels of H-CAM above the control (Fig 6) . Expression ofprogenitor-associated antigens. As CD18-Ad cells appeared to be highly enriched in progenitors of all lineages, we examined the expression among these cells of antigens that are known to be selectively expressed in progenitor cells, but absent in more mature cells, eg, CD34.I6 As anticipated, cells expressing CD34 were enriched in CD18-Ad cells (Fig 7) . The expression of CD34 was mainly among the large, blastlike cells that gave rise to the highest number of colonies in vitro (Fig 3) . HLA-DR( +) cells were also enriched in CD18-Ad cells, suggesting that fetal progenitors, primarily BFUe, have high expression of both CD34 and DR antigens. In contrast to CD34 and DR, only a minor positivity was observed with CD33 (LAF3) antigen in CD18-Ad cells. This was confirmed in additional experiments in which we used two different anti-CD33 antibodies (data not shown). These data suggest that the great majority of fetal BFUe are devoid of CD33 antigen, in contrast to variable CD33 positivity of adult BFUe.16, '7 For personal use only. on October 30, 2017. by guest www.bloodjournal.org From To further define the relationship between CD34 and p2
integrins in progenitor cells, especially to see whether the character of colonies produced is related to the level of expression of one or both of these molecules, we performed double labeling of CD18-Ad cells with anti-LFA-1-FITC and biotinylated anti-CD34 (12.8) followed by streptavidin-PE. The profile of the doubly labeled CD18-Ad cells is shown in Fig 8 (right, upper) . The great majority of cells appear to coexpress both CD34 and CDlla. However, minor populations expressing mainly CD34 or negative for both antibodies were present. These were cultured separately. Cells labeled strongly for both CD34 and Cdlla (designated + + I + +) contained the highest proportion of total clonogenic progenitors (Fig 8) . Somewhat fewer progenitors were present in CD34'/Cdlla+ cells (+/+) and much fewer were present in cells either positive with only one antigen or negative for both. The spectrum of colonies produced by ++I++, +/+, -I+, and -1-populations was evaluated and the data are shown in Fig S. The majority of colonies present in the +I+ population were of BFUe type, whereas the predominant colony type in ++/++ cells was the CFU-GM + M. These data suggest that fetal erythroid progenitors as a whole express CDlla less intensely than CFU-GM progenitors.
DISCUSSION
The data presented herein provide strong evidence for the presence of the CDllalCD18 (a,/&) integrin on early erythroid hematopoietic progenitors (BFUe), its progressive loss as progenitors reach the CFUe stage, and its absence at the stage of morphologically recognizable erythroblasts. As CDlla is also present on nonerythroid progenitors, our findings suggest a regulatory scheme for aL involving a selective restriction of its expression in late erythroid cells, rather than a progressive activation during granulomonocytic differentiation. However, the latter regulatory pathway seems to hold true for CDllb/CDl8 (or a,/&) integrin; this molecule is virtually absent in all types of progenitors, whereas it is highly expressed in mature granulomonocytic cells. Thus, our data add new information on the regulation of aL and aM integrins during hematopoietic differentiation, as they uncover their divergent expression patterns at early stages of hematopoietic differentiation.
Previous experiments studying human bone marrow have concluded that CDlla (LFA-I), as well as CDllb (Mac-1), are not present in bone marrow progenitor cells.' These results are in contrast to our studies here and to earlier studies on murine bone marrow," which have also suggested the presence of LFA-1 (aL/p,) but not the Mac-1 (a,lp,) molecule in all progenitors. The reasons for these discrepant results are not immediately apparent. Adult bone marrow was used in the previous study, whereas we used fetal liver. Whether expression of LFA-1 is less pronounced in adult than in fetal progenitors remains to be seen. However, we consider this an unlikely possibility. Instead, differences are likely attributable to the design of the experiments, specifically the use' of a mixture of antibodies to both CDlla and CDllb molecules for FACS separation of adult bone marrow cells. Recent observations" on CD18 positivity among CD34( +) cells from adult bone marrow would support the above conclusion.
It is of significant interest that the population we have isolated through immune adherence to anti-p, integrin appears to be expressing other cytoadhesion molecules, such as I-CAM and H-CAM. I-CAM, the counterreceptor for CDlla,'" also follows the same regulation as CDlla because restriction of its expression was observed in late erythroid cells. Recent studies in adult bone marrow cells also reported presence of H-CAM" and I-CAM" in a fraction of erythroid progenitors from adult bone marrow.
In addition to pz integrins, early erythroid progenitors (BFUe) (present in CD18-Ad cells), also express PI integrins, specifically cw, (VLA-4) and less so as (VLAJ). In contrast to pz integrins, p1 integrins of the a, family continue to be expressed at the erythroid precursor level (Fig 6) . These data expand previous information on the expression of a, and a5 integrins at the CFUe and erythroblast level in adult bone m a r r o~. '~~~~ However, in contrast to these previous data, we find significantly higher expression of a, compared with as at both the progenitor and precursor level (Fig 6) . The predominant expression of aq molecules suggests that adherence of fetal erythroid cells to components of extracellular matrix (fibronectin) may be primarily mediated through a, rather than a5 molecules. Furthermore, as expression of VLA-4 is not present in granulocytes but is present in p r o g e n i t o r~,~~~~~ erythroblasts, monocytes, and lymphoid cells,' restriction of its expression only during granulocytic differentiation is analogous to CDlla restriction only during erythroid differentiation.
The CD18-Ad population is highly enriched in cells expressing early hematopoietic antigens, ie, CD34 and HLA-DR.16 This was indicated by the significant enrichment in CD34-positive cells, or DR-positive cells, in CD18-Ad compared with CD18-NAd cell populations, and further confirmed by the findings in double-labeling experiments with anti-CD34 and anti-LFA-1 antibodies. Although our experiments document a high degree of overlap between CD34 and CDlla expression in erythroid and nonerythroid progenitors, they have not examined the hierarchical relationship between the two antigens during hematopoietic differentiation, specifically whether pre-CFU progenitors are in fact positive only for CD34 or both CD34 and CDlla expression. These issues are being addressed with experiments in progress.
What is the functional significance of expression of p2 integrins at the progenitor level? It is unclear at this point whether these molecules are functional, and if so, how important their particular function is in hematopoietic differentiation. It is possible that they remain at a lowErythroblasts FlTC Fluorescence For personal use only. on October 30, 2017. by guest www.bloodjournal.org From affinity state' without significant participation in adhesive reactions. It is also possible that the structure of aL protein at the progenitor level may not be identical (ie, differences in glycosylation) to the one present at the mature leukocyte and this may have different functional implications.
A clinical setting in which a deficiency of p2 integrins exists, ie, the leukocyte adhesion deficiency (LAD) ~yndrome,~ may provide some insight. LAD patients do not appear to have decreased hematopoietic function in quantitative terms and differentiation of progenitors of all lineages does not appear to be impaired. This could be either because of the nonfunctional, low-affinity state of these integrins at the progenitor level, or most likely, because there is a redundancy in cytoadhesion molecule expression at this level, permitting the function of one specific integrin (eg, LFA-1) to be substituted for another (eg, VLA-4).
The response of CD18-Ad fetal progenitors to cytokines is of interest. As previously noted in other experiments with unpurified or purified progenitors (purified using CD34 or 
